KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Acadia Pharmaceuticals (ACAD) Cost of Revenue (2016 - 2025)

Acadia Pharmaceuticals has reported Cost of Revenue over the past 10 years, most recently at $26.2 million for Q4 2025.

  • Quarterly results put Cost of Revenue at $26.2 million for Q4 2025, up 20.28% from a year ago — trailing twelve months through Dec 2025 was $89.0 million (up 8.75% YoY), and the annual figure for FY2025 was $89.0 million, up 8.75%.
  • Cost of Revenue for Q4 2025 was $26.2 million at Acadia Pharmaceuticals, up from $21.6 million in the prior quarter.
  • Over the last five years, Cost of Revenue for ACAD hit a ceiling of $26.2 million in Q4 2025 and a floor of $1.7 million in Q1 2023.
  • Median Cost of Revenue over the past 5 years was $12.7 million (2021), compared with a mean of $12.1 million.
  • Biggest five-year swings in Cost of Revenue: plummeted 77.54% in 2022 and later skyrocketed 1276.78% in 2024.
  • Acadia Pharmaceuticals' Cost of Revenue stood at $10.7 million in 2021, then plummeted by 77.54% to $2.4 million in 2022, then surged by 641.44% to $17.9 million in 2023, then grew by 21.87% to $21.8 million in 2024, then rose by 20.28% to $26.2 million in 2025.
  • The last three reported values for Cost of Revenue were $26.2 million (Q4 2025), $21.6 million (Q3 2025), and $20.7 million (Q2 2025) per Business Quant data.